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Biotinylation of Single Cysteine Mutants
of the Glutamate Transporter GLT-1 from Rat Brain
Reveals Its Unusual Topology
importance of GLT-1 in brain function has been illus-
trated by knockout experiments (Rothstein et al., 1996;
Tanaka et al., 1997).
Recently, a number of advances toward our under-
standing of the structural basis of transporter function
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Jerusalem 91120 have been made. A stretch of 76 amino acids that con-
tains at least part of the binding site of the nontrans-Israel
portable glutamate analog dihydrokainate has been
identified (Vandenberg et al., 1995). Two adjacent amino
acids that are involved in the binding of the couplingSummary
ions (Kavanaugh et al., 1997; Zhang et al., 1998) are
located right in the middle of this stretch. It is highlyIn the central nervous system, (Na1 1 K1)-coupled glu-
conserved not only between the five glutamate isotrans-tamate transporters restrict the neurotoxicity of this
porters but also in small neutral amino acid transporterstransmitter and limit the duration of synaptic excitation
(Arriza et al., 1993; Shafqat et al., 1993; Kekuda et al.,at some synapses. The various isotransporters exhibit
1996; Utsunomiya-Tate et al., 1996) as well as in bacte-a particularly high homology in an extended hydropho-
rial glutamate and dicarboxylic acid transporters (Tolnerbic domain of ill-defined topologythat contains several
et al., 1995). Nevertheless, further progress for the un-determinants involved in ion and transmitter binding.
derstanding of the molecular basis of glutamate trans-Here, we describe the determination of the membrane
port, including its possible malfunction in pathologicaltopology of the cloned astroglial glutamate transporter
states, is hampered by a lack of structural informationonGLT-1. A series of functional transporters containing
the transporters. For instance, the previously discussedsingle cysteines was engineered. Their topological
stretch containing substrate and ion binding sites isdisposition was determined by using a biotinylated
part of a large hydrophobic region (residues 340±490 insulfhydryl reagent. The glutamate transporter has
Figure 1) of still unresolved topology.eight transmembrane domains long enough to span
In fact, three different transmembrane topology mod-the membrane as a helices. Strikingly, between the
els for the glutamate transporters GLAST-1 (Storck etseventh and eighth domains, a structure reminiscent
al., 1992), GLT-1 (Pines et al., 1992), and EAAC-1 (Kanaiof a pore loop and an outward-facing hydrophobic
and Hediger, 1992) have been proposed, although theirlinker are positioned.
hydropathy plots are almost identical. The three models,
however, agree onthe arrangement of thesix transmem-Introduction
brane a helices located in the amino-terminal part of the
transporters (see also Figure 7). Trypsinization studies,Glutamate neurotoxicity is restricted by transporters of
together with the use of sequence-directed antibodiesthis acidic amino acid located in the plasma membranes
against discrete parts of GLT-1, have demonstrated theof nerve and glial cells (Kanner and Schuldiner, 1987;
internal location of amino and carboxyl termini and theNicholls and Attwell, 1990; Rothstein et al., 1996; Tanaka
external location of the large glycosylated loop connect-et al., 1997). Moreover, at some synapses, glutamate
ing transmembrane helices 3 and 4 (Grunewald and Kan-transporters appear to be important in limiting the dura-
ner, 1995). Recently, attempts to experimentally deter-tion of synaptic excitation (Mennerick and Zorumski,
mine the topology of the astroglial transporter GLAST-11994; Tong and Jahr, 1994; Otis et al., 1996; Diamond
(Wahle and Stoffel, 1996) and the bacterial glutamateand Jahr, 1997). They achieve this by an electrogenic
transporter gltT (Slotboom et al., 1996) have been made.process (Kanner and Sharon, 1978; Brew and Attwell,
They revealed strikingly different apparent topologies1987; Wadiche et al., 1995), whereby the transmitter
for the highly important large hydrophobic region. Whileis cotransported with three sodium ions and a proton
it cannot be ruled out a priori that bacterial and eukary-(Zerangue and Kavanaugh, 1996) followed by coun-
otic transporters may exhibit a different topological or-tertransport of a potassium ion (Kanner and Bendahan,
ganization, we consider this unlikely. In both studies,1982; Pines and Kanner, 1990; Zerangue and Kava-
use was made of truncated constructs fused to reporternaugh, 1996; Kavanaugh et al., 1997).
groups, which are intrinsically devoid of transport activ-The astroglial glutamate transporter GLT-1 has been
ity. Therefore, it is possible that at least some of thepurified from rat brain tonear homogeneity and reconsti-
fusion proteins are folded in a nonnative conformation.tuted (Danbolt et al., 1990, 1992). It has been cloned
Here, we report that when biotinylation of functional(Pines et al., 1992) and is relatedÐat z50% sequence
single cysteine containing GLT-1 transporters is moni-identityÐto three different glutamate transporters from
tored, an unusual membrane topology is uncovered. Itthe central nervous system (Kanai and Hediger, 1992;
appears that the large hydrophobic region consists ofStorck et al., 1992; Fairman et al., 1995) as well as one
two transmembrane domains and, between them, afrom the retina (Arriza et al., 1997). The physiological
structure reminiscent of the pore loops observed both
in voltage-gated channels and in some ligand-gated
channels.*To whom correspondence should be addressed.
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Figure 1. Hydropathy Plot of GLT-1
The hydropathy plot was done according to the scale of Kyte and
Doolittle (1982) by using a window of 21 amino acids. Also shown
are the transmembrane domains determined in this study, with the
numbering used in the topological model (Figure 7).
Results
Biotinylation of GLT-1 and Its Single Cysteine
Derivative V417C
A typical experiment, in which biotinylated GLT-1 deriva-
tives are visualized, is shown in Figure 2A. HeLa cells
expressing the GLT-1 constructs were reacted with Figure 2. Biotinylation of GLT-1 and Its Single Cysteine Derivative
3-(N-maleimidylpropionyl)biocytin (BM). After solubili- V417C
zation of the membrane proteins, the histidine-tagged (A) HeLa cells expressing wild-type transporter (WT), the cyste-
(His-tagged) transporters were purified on nickel±nitrilotri- ineless mutant transporter (CL), their His-tagged derivatives (WT-H
and CL-H), and the V417C mutant (in the CL-H background) wereacetic acid (Ni±NTA) beads. The covalently bound biotin
washed twice with PBSCM and incubated for 5 min in PBSCM withis readily visualized afterSDS-PAGE by probing the blot-
or without 1 mM MTSET as indicated. The cells were washed againted proteins with streptavidin peroxidase. The biotinyl-
and incubated for 30 min at room temperature in the presence of
ated His-tagged GLT-1 (WT-H) runs as a broad band 500 mM BM. The cells were washed with PBSCM containing 2%
centered around 64 kDa, which is in good agreement (v/v) 2-mercaptoethanol and solubilized, and the solubilized cellular
with the apparent mobility of the heterologously ex- proteins were purified on Ni±NTA beads (as described in Experimen-
tal Procedures). The eluates were subjected to SDS-PAGE andpressed wild-type transporter (Pines et al., 1992). As we
transferred onto nitrocellulose, and biotinylated proteins were de-shall explain in the Discussion, this band represents an
tected with streptavidin conjugated to peroxidase and ECL. Theimmature monomeric form of the transporter that does
numbers on the left side represent the apparent molecular massesnot reach the plasma membrane. In addition, an aggre-
of the prestained molecular weight markers (New England Biolabs).
gated form of the transporter is observed as well (Figure Transport activity of the mutant V417C was 83% 6 3% (n 5 7) of
2A). The tagged transporter exhibits activity similar to the CL-H transporter.
(B) Immunoprecipitation of the band of lower mobility by anti±GLT-1.its nontagged counterpart (103% 6 4%, n 5 9). The
Cells expressing the mutant V417C were processed as describedlatter is obviously not purified on the Ni±NTA agarose
previously. The eluates from the Ni±NTA agarose beads (100 ml)beads (WT, Figure 2A). In this case, only a number of
were processed as in Figure 2A (two lanes on the left) or diluted 1:3
nonspecific bands light up, which is also observed in in a solution containing 0.15% SDS, 0.9% Triton X-100, 7.5 mM Na
HeLa cells expressing the vector pBluescript SK2 alone EDTA, and 15 mM NaPi (pH 7.4). They were then incubated with 10
(data not shown), the cysteineless version of GLT-1 (CL), mg of protein A-Sepharose CL-4B to which 10 ml of either P694
antiserum (GLT-1) or GAT-1 (GABA transporter) antiserum was pre-or any other of the transporter constructs (Figure 2A).
bound as indicated. After 3 hr of incubation by end-over-end shakingNo specific transporter bands are observed with CL
in the cold room and centrifugation, the supernatants were sub-tagged with a deca-His tail (CL-H, Figure 2A). Upon
jected to SDS-PAGE. Biotinylated proteins were detected as de-
expression, both CL constructs exhibit significant trans- scribed previously.
port activityÐ44% 6 2% (n 5 7) of the wild type. More-
over, their transport characteristics, such as affinity for
sodium and the nonmetabolizable transporter substrate When a single cysteine is introduced into the con-
struct by replacing valine-417 (V417C), our biotinylationD-aspartate, were very similar to that of the wild-type
GLT-1 (data not shown). Therefore, we have used the protocol results in the appearance of a broad band with
a lower mobility than that of the monomeric wild-typeHis-tagged construct (CL-H) as the basis for the topol-
ogy determination. transporter (Figure 2A). The transport activity of V417C
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Figure 3. MTSET-Sensitive Labeling of Sin-
gle Cysteine-Containing GLT-1 Transporters
HeLa cells expressing His-tagged single cys-
teine mutant transporters were processed
with or without 1 mM MTSET as described in
Figure 2A. Similarly tagged wild-type (WT-H)
and cysteineless GLT-1 (CL-H) were used as
controls. The mutants retained significant
transport activity, ranging between 50%±
120% of that of CL-H, except for L465C,
23% 6 5% (n 5 2); V75C, 55% 6 2% (n 5 3);
S443C, 62% 6 2% (n 5 3); G422C, 116% 6
1% (n 5 3); E306C, 52% 6 3% (n 5 2); L451C,
68% 6 4% (n 5 3); and T460C, 54% 6 10%
(n 5 3). The biotinylation state of each of the
mutants shown was verified in at least three
independent experiments.
transporters is not compromised by the introduction of have found that A309C and R310C behave similarly.
This further supports the external location of the loopthe single cysteineÐ83% 6 4% of CL-H (n 5 7). Another
important difference between wild-type and V417C connecting domains 5 and 6. We now ventured into
unknown territory, namely the region of ambiguity be-transporters is that preincubation of the cells express-
ing these transporters with the membrane-impermeant yond TM 6. Out of the many single cysteines inserted,
only the ones indicated in Figure 3, as well as V417Csulfhydryl reagent 2-trimethylammoniumethylmethane-
thiosulfonate (MTSET) (Holmgren et al., 1996; Olami et (Figure 2A) and S464C (data not shown), were biotinyl-
ated in a MTSET-sensitive fashion and thus appear ac-al., 1997) blocks biotinylation in the case of V417C only
(Figure 2A). This suggests that the cysteine introduced cessible from the outside (Figure 7). The transport
activity of all of these single cysteine mutants was 50%±at the 417 position is accessible from the external me-
dium. On the other hand, all of the nine cysteines en- 120% of CL-H, except for S464C and L465C, which were
z20% of CL-H. All of the other positions probed (Figuredogeneous in the wild-type are either facing the cyto-
plasm or are otherwise not accessible. The labeling of 7) scored negative in thebiotinylation assay, as exempli-
fied in Figure 4 for many of them. Functionally, the cyste-the internal cysteines is less than the single cysteine
present in V417C, probably because of poor membrane ine replacement was tolerated well at most positions.
The transport activity of the replacement mutants shownpermeability of the BM and perhaps also because of a
reducing environment in the cytoplasm. The specific in Figure 4 ranged between 50%±140% of CL-H. In some
of the others (see figure legend), the activity was lowerbiotinylated band observed with V417C represents the
transporter, because it can be immunoprecipitated with (15%±40%). Even in these, there are enough positions
where higher activity was observed nearby (see alsoan antibody directed against GLT-1 but not with one
directed against the (Na1 1 Cl2)-coupled GABA trans- Figure 5B). This gives us confidence that the topological
assignment made (see Discussion) is correct.porter GAT-1 (Figure 2B).
A negative result in the biotinylation of single cysteine
transporters is ambiguous; it can mean that the residueBiotinylation of Single Cysteine GLT-1 Transporters
To identify additional sites exposed to the outside, we in question is either internal or located in hydrophobic
surroundings within the membrane. Other possibilitieshave introduced single cysteines at many positions of
the cysteineless His-tagged GLT-1 (CL-H). The internal are that it is facing an aqueous access channel within
the membrane too narrow to be accessible to the bulkylocation of the amino terminus of GLT-1 is well estab-
lished (Grunewald and Kanner, 1995). The hydropathy BM, or it even could be external but in an environment
that has a secondary structure such that the residue isplot of the amino-terminal part of GLT-1 has six pro-
nounced hydrophobic stretches that are long enough to inaccessible. A residue facing the cytoplasm isexpected
to become accessible to BM after gentle permeabiliza-span the membrane as a helices (Figure 1). This predicts
three external loops in this part of the transporter. As tion of the membrane. Moreover, according to the re-
sults depicted in Figure 2, its mobility should be that ofthe external location of the loop connecting domains 3
and 4 has also been established (Grunewald and Kanner, the major intracellular species of 64 kDa. In the experi-
ment shown in Figure 5A, it can be seen that this is1995), we tested the external location of position 75,
located in the loop connecting transmembrane domains precisely what happens. When streptolysin O (SLO) is
used to permeabilize HeLa cells expressing S113C,(TM) 1 and 2 as well as that of position 306 in the loop
connecting domains 5 and 6. The experiment shown V266C, or S373C transporters, they become accessible
to the biotinylation reagent. In other positions, the singlein Figure 3 illustrates that when single cysteines are
introduced at positions 75 and 306, biotinylation that is cysteines introduced are not labeled under any condi-
tionÐnot even afterpermeabilization with SLO. The datasensitive to MTSET is observed. Since both V75C and
E306C retain significant transport activityÐ55% 6 2% shown in Figure 5A exemplify this for residues V59 and
S293, located in TM 1 and 5, respectively. The same is(n 5 3) and 54% 6 2% (n 5 2) of CL-H, respectivelyÐ
these results prove that these two loops are external true for tyrosine-403 (Figure 5A) as well as residues
E404, I407, I411, and Q413 (data not shown). Another(see Figure 7). Although the data are not shown, we
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Figure 4. Biotinylation of Single Cysteine-
Containing GLT-1 Transporters
The protocol followed was identical to that
described in Figure 3. MTSET (1 mM) was
added to probe the signals obtained with the
positive controls V417C and S443C (see also
Figure 3). The following mutant transporters
had relatively high transport activityÐbetween
50%±140% of CL-H: S113C, 51% 6 11% (n 5
2); S184C, 127% 6 8% (n 5 2); V266C,
142% 6 11% (n 5 2); F347C, 54% 6 4% (n 5
2); W354C, 61% 6 5% (n 5 3); G359C, 56% 6
3% (n 5 2); S373C, 100% 6 6% (n 5 4);
E404C, 104% 6 9% (n 5 2); M476C, 87% 6
4% (n 5 3); and E530C, 115% 6 9% (n 5 3).
Some of the other mutants exhibited signifi-
cant but somewhat lower activity (expressed
as a percentage of that of CL-H): G379C, 34% 6 2% (n 5 2); G392C, 28% 6 4% (n 5 2); Y403C, 34% 6 7% (n 5 3); A407C, 30% 6 2%
(n 5 3); I411C, 24% 6 1% (n 5 2); Q413C, 25% 6 1% (n 5 2); L433C, 15% 6 5% (n 5 3); A434C, 26% 6 1% (n 5 3), and S435C, 11% 6 1%
(n 5 3).
prediction for the behavior of cysteines facing the cyto- Discussion
plasm is that incubation with the impermeant MTSET
We have employed several approaches to determineprior to permeabilization with SLO should not block the
the topology of the glutamate transporter GLT-1. Resis-subsequent biotinylation by BM. On the other hand,
tance of epitopes of GLT-1 residing in oriented mem-preincubation with the highly permeant N-ethylmalei-
brane vesicles against proteolysis shows that the aminomide (NEM) should. Again, this is exactly what happens,
and carboxyl termini are inside the cell (epitopes P692as exemplified in the case of position 373 (Figures 5A
and P694, respectively; Figure 7), while the large loopand 5B). The same is true for all other positions that
connecting TM 3 and 4 (epitope P693, Figure 7) is extra-become accessible to BM after membrane permeabili-
cellular (Grunewald and Kanner, 1995). In extremely hy-zation by SLO, such as W354C, A431C, and E530C (Fig-
drophobic proteins such as GLT-1, the utility of thisure 5B) as well as G359C and G379C (data not shown).
method is limited by the number of epitopes suitableThus, this category of positions is therefore accessible
to generate high quality antibodies. Nevertheless, wefrom the inside, in contrast to those that are not labeled
found one more, P695, that allows for its unambiguousby BM, even after SLO treatment.
intracellular assignment (Figures 6 and 7). N-glycosyla-
tion scanning mutagenesis (data not shown) demon-Limited Proteolysis of GLT-1
strates that both N-glycosylation sites in the loop con-
Topology of membrane proteins can also be probed
necting TM 3 and 4 are usedÐin line with a similar
using limited proteolysis of an oriented membrane prep-
finding for the related glutamate transporter GLAST-1
aration. For example, cleavage of GLT-1 by trypsin at (Conradt et al., 1995). With this technique, we have ob-
an external site will yield fragments of the transporter in tained independent evidence that the loop connecting
which internal epitopes are protected by the membrane TM 1 and 2 is extracellular (data not shown). One draw-
(Grunewald and Kanner, 1995). The kinetics of thegener- back of this method is that lack of glycosylation at an
ation of the fragments is influenced by the conformation inserted site is not indicative of an internal location.
of the transporter, as seen here in the presence of gluta- Another is that in GLT-1, insertion of a consensus site
mate (Figure 6). After trypsinization of membrane vesi- often compromised the transport activity, making it im-
cles from rat brain for various times, GLT-1 or its frag- possible to draw any conclusions on the topology for
ments have been detected with a specific antibody most insertions tested.
against epitopes P695 (Figure 6A) and P694 (Figure 6B). On the other hand, the major method used here is
The specificity of anti-P694 has been established (Grune- very versatile; introduction of single cysteines usually
wald and Kanner, 1995); that of anti-P695 is demon- affects the transport activity only slightly. A special fea-
strated for trypsinization in the presence of glutamate ture of the modifications we have introduced in the tech-
in Figure 6C; 50 nmol of the P695 peptide abolished the nique is that it allows us to identify not only externally
immunoreactivity of fragments generated in the pres- exposed residues (Figures 2 and 3) but also internal
ence (Figure 6C) or absence (data not shown) of gluta- ones (Figure 5). The only cases in which it is impossible
mate. It can be seen that neither epitope is destroyed, to make an assignment are those in which no biotinyla-
and that in both cases, glutamate promotes the second- tion is observedÐeven after permeabilization by SLO.
ary cleavage of the 43 kDa fragment to one of 35 kDa, The mobility of mutant transporters with a single cys-
observed after 60 min of digestion. Glutamate also ac- teine accessible fromthe outside toboth BM and MTSET
celerates the cleavage of the dimeric form of the trans- is slower than the major 64 kDa species labeled in wild-
porter, as visualized with both antibodies (Figure 6). type GLT-1 (Figures 2 and 3). Immunoblot analysis re-
Thus, not only P694 (Grunewald and Kanner, 1995) but veals that a small amount of slower-moving transporter
also P695 has an internal location, and both epitopes can be detected in addition to the major 64 kDa species
with all of the GLT-1 mutants as well as with the wildare located on the 43 as well as the 35 kDa fragments.
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slower-moving transporter is residing in the plasma
membrane comes from surface-labeling experiments of
the His-tagged wild-type GLT-1. They indicate that the
plasma membrane form moves slower and represents
6%±8% of the total expressed transporters (E. R. Ben-
nett, M. Grunewald, and B. I. Kanner, unpublished data).
Interestingly, no biotinylated dimer forms of the V417C
transporters are detected (Figure 2A), but immunoblot-
ting reveals the presence of dimerized transporters. This
indicates that dimerization is a preferential property of
internal, immature, transporters rather than that of func-
tional ones expressed at the plasma membrane.
The findings obtained by the three different ap-
proaches lead to the topological model illustrated in
Figure 7. By using the P692 epitope, the amino terminus
was already shown to be internal (Grunewald and Kan-
ner, 1995). The first three extracellular loops are external,
as evidenced by the biotinylation at position 75 in loop
1 and at 306, 309, and 310 in loop 3 (Figures 3 and
7); the N-linked glycosylation of a consensus sequence
introduced in loop 1 at position 76; and the usage of
the two endogenous glycosylation sites located in extra-
cellular loop 2 (data not shown). This reinforces our
earlier conclusion of loop 2 using epitope P693 (Grune-
wald and Kanner, 1995). Biotinylation at positions 113
and 266 is only observed after permeabilization with
SLO (Figures 4 and 5), indicating the internal location
of the loop connecting domains 2 and 3 as well as that
Figure 5. Effect of SLO Treatment on Cells Expressing Single Cyste- connecting domains 4 and 5. Thus, our findings for this
ine GLT-1 Transporters part of the transporter (Figure 7) are in line with the
HeLa cells expressing single cysteine mutant transporters and His- predictions made from the hydropathy plot (Figure 1)
tagged derivatives of the wild-type (WT-H) and cysteineless (CL-H) by several groups (Kanai and Hediger, 1992; Pines et
transporters were processed as described in Figure 2A. The wild
al., 1992; Storck et al., 1992). The hydropathy plot of thetype (WT) was used as an additional control. Where indicated, a
rest of the molecule is very difficult to interpret (Figurepreincubation step with 1 mM MTSET or 1.5 mM NEM was carried
1); attempts by two groups to determine the topologyout prior to SLO treatment. The results, documenting examples of
external, internal, and nonaccessible cysteines, are shown in (A). of this region led to conflicting results (Slotboom et al.,
Those illustrating most internal cysteines are shownin (B). The meth- 1996; Wahle and Stoffel, 1996). Our findings (Figures 5
odology followed for the preincubation and subsequent permeabili- and 6) indicate that the entire stretch connecting TM
zation and biotinylation was exactly as described in Experimental
6 and 7 is intracellular (Figure 7). They are based onProcedures. The transport activity of the mutant transporters V59C
biotinylation at positions 354, 359, 373, and 379 (Figureand S293C was similar to that of the His-tagged cysteineless GLT-1
5B) as well as the resistance of the P695 epitope againsttransporter CL-H (97% 6 3% [n 5 3] and 98% 6 1% [n 5 3],
respectively). The activity of the A431C mutant transporter was trypsinization (Figure 6). There must be a transmem-
52% 6 4% (n 5 3) of that of CL-H. brane span between position 386, the most carboxy-
terminal amino acid residue of epitope P695, and the
externally accessible position 417 (Figures 2±5). This
type. In fact, the proportions of these two species are stretch, domain 7 (Figure 7), is long enough to span the
similar in wild type and mutants (data not shown). In membrane as an a helix, for which z20 residues are
the case of an external cysteineÐsuch as V417CÐBM needed. In line with this, positions 392, 403, 404, 407,
reacts only with the slower-moving species in an 411, and 413 are not accessible to the biotinylating re-
MTSET-sensitive fashion (see also Figure 4). This indi- agent (Figure 4), not even from the inside, as shown for
cates that this slower-moving species represents the the 403 position (Figure 5A). These observations empha-
mature form that reaches the plasma membrane, while size one limitation of the technique, namely, the inability
that of 64 kDa represents an immature form residing in to determine the precise boundaries of the transmem-
internal membranes. The 64 kDa form of V417C is hardly brane domains. It seems likely that even one or two
biotinylated, because the single cysteine is expected to residues away from the membrane borders, the accessi-
point to the inside of the internal membranes; the poorly bility of the reagent may be poor. Moreover, there are
permeant reagent would need to cross two membranes cases where residues located in extracellular (position
in order to label it. Even after treatment of the cells with 184) or intracellular (positions 347 and 349) loops are not
SLO, the 64 kDa form of V417C is almost not labeled at labeled. This is possibly due to the secondary structure
all (Figure 5). This indicates that internal organelles are around these positions.
not permeabilized under these conditions, as expected A striking observation is that between the external
from our experimental protocol (see Experimental Pro- positions 422 and 443 (Figure 3), residue 431 reacts
with BM from the inside (Figure 5B). Since the cysteinecedures). Independent evidence for the idea that the
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Figure 6. Immunoreactivity of Tryptic Frag-
ments of GLT-1 Generated in the Presence
and Absence of Glutamate
Membrane vesicles were loaded with 135 mM
NaCl and 10 mM NaPi (pH 7.4) and treated
with trypsin for the times (min) indicated in
the presence or the absence of 1 mM L-gluta-
mate at 378C. After Tricine±SDS-PAGE (z70
mg of membrane proteins per lane), the sam-
ples were immunoblotted with affinity-puri-
fied anti-P695 antibodies diluted at 1:100
(Figure 6A) or with the same solution of anti-
bodies to which 50 nmol of the P695 peptide
was added prior to incubation (Figure 6C).
The blot shown in Figure 6A was stripped
with 62.5 mM Tris-HCl (pH 6.7), 2% SDS, and
100 mM 2-mercaptoethanol for 45 min at
508C. After washing in PBS containing 0.2%
Tween-20, the blot was reprobed with the
anti-P694 antibody (Figure 6B).
introduced at this position acts as a reporter group for exposure to NEM before permeabilization but not to
MTSETÐit meets the criterion for an internal residuethe key residue A431, we have given the labeling at this
position extra attention. With our assayÐlabeling by not only qualitatively but also quantitatively (Figure 5B).
Thus, quantitation of the labeling by scanning the bandsBM after streptolysin treatment, which is sensitive to
Figure 7. Revised Topological Model of GLT-1
Residues that were mutated to cysteines are indicated by their position number. The results of labeling with BM are indicated: closed circles,
the mature form of the transporter is labeled with 500 mM BM, and labeling is blocked by preincubation with MTSET; stars, the immature
form is labeled with 500 mM BM only after permeabilization with SLO, and this labeling is blocked by preincubation with NEM but not with
MTSET; and open circles, no labeling under either condition. P692, P695, and P694 are stretches of amino acids (dotted circles) that were
shown to be internal in trypsinization studies. By using the same method, P693 was shown to be extracellular (Grunewald and Kanner, 1995).
N205 and N217 were shown to be used as native glycosylation sites (y-shaped symbols). The transmembrane domains that are long enough
to cross the membrane as a helices are indicated by Arabic numerals, and the two legs of the reentrant loop are indicated by Roman numerals.
The presumed boundaries of domains 1±8 are indicated as well.
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reveals that the intensity of the labeling of A431C is Wahle and Stoffel, 1996), especially at the long hy-
drophobic domain between residues 340±490. Some92% 6 16% (n 5 4) of that of E530C, located at the
carboxy-terminal tail of the protein. The latter is firmly features were also inferred by Slotboom et al. (1996),
but they predict two additional transmembrane a helicesestablished to be internal (Grunewald and Kanner, 1995;
Figures 5B and 6). Since maleimides are highly reactive, between TM 7 and 8. According to their model, the
residues equivalent to A431, L451, and T460 are buriedthey would be expected to react very fast with an ex-
posed cysteine (Krishnasastry et al., 1994). This is in- in transmembrane domains, while S443 is facing the
cytoplasm. Our data unambiguously show that A431 isdeed the case for A431C. Although generally a reaction
time of 30 min was used, the same level of labeling was cytoplasmic, and the three others are extracellular. The
model of Wahle and Stoffel (1996) exhibits only a fewalso obtained after 2 and 10 min, both for A431C and
E530C (data not shown). Thus, there are two apparent of the features found in our studyÐthe prediction of a
transmembrane domain not far from but shorter thanmembrane spans, I and II, within a stretch of only 22
residues (Figure 7). Consistent with this are our observa- TM 8 as well as the external location of the hydrophobic
linker between residues S443 and L465 and that of thetions that single cysteine mutants at positions 433±435
were not biotinylated, not even after treatment with SLO few residues surroundingV417. These investigators pro-
pose that two short transmembrane b sheets separating(data not shown). The arrangement of segments I and
II is unconventional for transporters and is reminiscent the region corresponding to the P695 epitope are lo-
cated between TM 6 and 7. They place this epitope onof pore loops from ion channels (MacKinnon, 1995). The
pore loop of voltage-dependent ion channels is a stretch the outside. This is in contrast with our data based both
on biotinylation of functional transporters and on trypsi-of residues that influences single channel current ampli-
tude selectivity among ions and open channel blockade nation studies. It is likely that the differences between
our studies and the published ones are due to nonnative(Hartmann et al., 1991; Yellen et al., 1991; Heginbotham
et al., 1994). Recently, the structure of a related potas- conformations of some of the inactive fusion proteins
employed in the published studies.sium channel containing a pore loop was solved (Doyle
et al., 1998). A region critical for the ion selectivity of It is interesting to examine the localization of some
of the amino acid residues of glutamate transporters,glutamate receptors also appears to be folded as a pore
loop (Kuner et al., 1996). Although no homology between which have been found to play an important role in their
function and which are located in the highly conservedthe region encompassing segments I and II and the pore
loops of voltage-dependent ion channels or of glutamate large hydrophobic domain. Recently, we have identified
two neighboring residues of GLT-1, tyrosine 403 andreceptors can be detected, it is possible that this region
is folded in such a way. However, it appears that one glutamate 404, which appear to be involved in potas-
sium binding (Kavanaugh et al., 1997; Zhang et al., 1998)feature of pore loops is that the apex does not reach
the levels of the phospholipid headgroups on the other and are close to one of the sodium binding sites (Zarbiv
et al., 1998; Zhang et al., 1998). Moreover, tyrosine 403side of themembrane (Doyle et al., 1998). The accessibil-
ities of G422, S443, and A431 could be compatible with behaves as if it is alternately accessible to either side
of the membrane (Zarbiv et al., 1998). These observa-this, but this would require an aqueous access channel
wide enough to permit the bulky BM to reach the 431 tions on Y403C transporters were made using the small
sulfhydryl reagents (2-aminoethyl)methanethiosulfonateposition from the inside. Alternatively, segments I and
II may be truly transmembrane. In this case, however, (MTSEA) and MTSET. This suggests that these small
reagents can penetrate from the outside through partthese segments cannot be a helical throughout. An a
helix containing nine residues has a length of only 13±14 of the permeability pathway and reach the 403 position.
BM cannot (Figures 4 and 5A), probably owing to itsAÊ , as compared with the z30 AÊ needed to cross the
membrane. However, a more extended conformation of larger size. Thus, it appears that BM only reacts with
cysteines exposed to the aqueous phase on either sidethe segments would be of sufficient length to do so. A
b strand of nine amino acids has a length of z30 AÊ . It of the membrane or with those lining the wall of the wide
part of an aqueous permeability pathway through theis likely that this issue can only be resolved after suc-
cessful crystallization and structure determination of transporter. Nearby residues 403 and 404 are the essen-
tial residues 396±400, which are prime candidates toGLT-1. Carboxy-terminal to segments I and II, there is
a short, very hydrophobic stretch (Figure 1) containing participate in sodium binding (Zarbiv et al., 1998; Zhang
et al., 1998). All of these residues are part of the newlyexternally accessible residues 451, 460, and 465 (Figure
3) as well as residue 464 (data not shown). Because of identified TM 7. Sodium binding is very sensitive to the
membrane potential, suggesting that it binds in the elec-its high hydrophobicity, this loop is probably close to
the membrane. It may be located at the external mouth tric field that exists across the membrane (Wadiche et
al., 1995). The topology of GLT-1 suggests that if sodiumof the pore, possibly shielding some hydrophobic resi-
dues in the wall of the permeation pathway from the indeed binds to residues 396±400, there should be an
access channel going almost entirely through the trans-aqueous lumen. Finally, between the external position
465 and the internal P694 epitope, there must be one porter (Figure 7). The novel TM 8 is the site of the critical
aspartate 470 (Pines et al., 1995) and arginine 477 (Con-more transmembrane stretch (TM 8, Figure 7). The inter-
nal location of the carboxyl terminus is independently radt and Stoffel, 1995).
It is anticipated that the unique topology of GLT-1,confirmed by the fact that residue 530 is only biotinyl-
ated in SLO-permeabilized cells (Figure 5B). and apparently of the other members of the glutamate
transporter family, will give important clues to delineat-The topology that we have determined is significantly
different from that reported (Slotboom et al., 1996; ing binding sites of substrates and substrate analogs.
Neuron
630
diameter) and transfected (Keynan et al., 1992) with the cDNA en-For example, it was established that a stretch of 76
coding wild-type or mutant transporters. About 20 hr after transfec-amino acid residues, from 364±439, contains part of the
tion, the cells were washed twice with 4 ml of ice-cold PBSCM.binding sites for glutamate and dihydrokainate (Vanden-
Subsequently, 1 ml of PBSCM (room temperature) with or without
berg et al., 1995). Since the affinity for kainate is almost MTSET (1 mM, Toronto Research Chemicals) or NEM (1.5 mM) was
independent of the membrane potential (Wadiche et al., added to each well. After 5 min of incubation, the solution was
aspired, and the cells were washed twice with 4 ml of ice-cold1995), it appears that its binding sites are close to the
PBSCM. This was followed by the biotinylation step, which wasexternal surface of the membrane. The new topology
performed by a 30 min incubation with 500 mM BM (Molecularwould predict thecandidate residues to be located in the
Probes) in PBSCM at room temperature. All subsequent steps wereexternal part of domains 7, I, and II. The determination of
performed on ice. After extensive washing, once in PBSCM con-
the unusual topologyÐwhich could not be predictedÐ taining 2% (v/v) 2-mercaptoethanol and twice with PBSCM alone,
will be of great importance for studies directed to gain the cells were lysed using 1.2 ml of lysis solution containing 0.5
M NaCl, 1% Triton X-100, 0.25 mM phenylmethylsulfonyl fluorideinsights into the structural basis of transporter function.
(PMSF), 0.05 M imidazole, and 0.05 M NaPO4 (pH 7.4) per well. After
20 min, the insoluble material was removed by centrifugation in a
Experimental Procedures microcentrifuge for 15 min. The supernatant from each well was
incubated with 100 ml of Ni±NTA agarose beads (Qiagen) preequili-
Site-Directed Mutagenesis brated in lysis solution for 30 min by end-over-end shaking. Preequil-
Removal and insertion of N-linked glycosylation sequences orcyste- ibration was performed by addition of nine volumes of lysis solution
ines and addition of ten His residues to the transporter were per- per volume of Ni±NTA beads and end-over-end shaking in the cold
formed using site-directed mutagenesis according to the method room for 4 hr. This was followed by centrifugation and aspiration
of Kunkel as described (Kunkel et al., 1987). At least two independent of the supernatant. After incubation with the solubilized cellular
transformants harboring the mutant plasmids were characterized proteins, the beads were washed twice with 1 ml of lysis solution,
by transport activity. twice with a solution containing 0.5 M NaCl, 1% Triton X-100, 0.08
All mutants giving positive results were subcloned into the parent M imidazole, and 10 mM Tris-HCl (pH 7.4). The proteins were eluted
construct by using unique restriction sites, and the inserts were by incubation with 100 ml of solution containing 0.5 M NaCl, 1%
sequenced in both directions between these sites. Triton X-100, 0.25 M imidazole, and 10 mM Tris-HCl (pH 7.4). When
Heterologous expression of wild-type or mutant transporters was indicated in the figure legends, cells were permeabilized with SLO
performed in HeLa cells infected with the vaccinia/T7 recombinant (Sigma Chemicals) immediately before the biotinylation step. For
virus followed by transfection by N-(1-[2,3-dioleoyloxy]propyl)- this, an aliquot of the SLO stock solution (25,000 U/ml of H2O) was
N,N,N-trimethylammoniummethylsulfate (DOTAP) (Boehringer, Mann- diluted 100-fold into SLO buffer containing 2.5 mM MgCl2, 1 mM
heim) exactly as described (Keynan et al., 1992). Transport using DTT, 115 mM potassium acetate, and 25 mM HEPES/KOH (pH 7.4)
D-[3H]-aspartate (10.5 Ci/mmol, DuPont NEN) was performed as in and kept on ice for at least 10 min. To each well, 1 ml of this solution
Pines et al. (1995). The substrate was used at 0.19 mM, a nonsaturat- was added, and the cells were incubated on ice for 15 min. After
ing concentration. The data are not normalized for the amount of aspiration of the excess of SLO, the cells were washed twice with
transporter expressed, but expression levelsÐas judged by immu- 4 ml of cold SLO buffer followed by a 30 min incubation at 378C
noblottingÐwere similar in all of the mutants tested (data not with 1 ml of SLO buffer prewarmed to this temperature. This last
shown). step causes the formation of pores in the plasma membrane. The
cells were washed with SLO buffer and then with PBSCM, and this
was followed by the biotinylation step.Construction of the Cysteineless, His-Tagged
To the eluates from the Ni±NTA beads was added 6-fold concen-Mutant GLT-1
trated SDS-PAGE sample buffer containing 2-mercaptoethanolThe six native cysteines of the wild-type transporter at positions
(18%). After SDS-PAGE, they were transferred onto nitrocellulose,38, 60, 184, 293, 296, and 373 were each replaced by serine by
and the biotinylated proteins were detected by using streptavidin-sequential site-directed mutagenesis. The other three, at positions
peroxidase and enhanced chemiluminescence (ECL) (Amersham)536, 549, and 562, are part of the stretch from residue 533 to residue
according to the instructions of the manufacturer. For each of the563 that was deleted by site-directed mutagenesis. This technique
mutants, determination of accessibility to BM was performed atwas also used to insert the deca-His tail between the last residue
least three times. For important residues, there were many moreof GLT-1, lysine 573, and the stop codon. A segment of the sequence
repeats; for example: V417C, 21; G422C, 15; A431C, 11; S443C, 9;MHFVLR34D followed by the first 41 amino acid residues of the
and E530C, 14.GABA transporter GAT-1 was prepared by PCR by using GAT-1 as
a template. The primers used for amplification were designed such
Preparation of Membrane Vesicles, Tryptic Digestion,that both ends of the amplified fragment contained a StuI site. After
and Preparation and Purification of Antibodiesdigestion with this enzyme, the fragment was ligated into blunt ends
These were done exactly as described (Grunewald and Kanner,created in the cysteineless, His-tagged GLT-1 construct by cutting
1995). P695 antiserum was raised in rabbits against a peptide corre-it with PflmI and removing the 39 overhangs with T4-polymerase. sponding to residues 372±386 (RCLEDNLGIDKRVTR; Pines et al.,The result is that 48 amino acids are inserted immediately amino-
1992). The antiserum was purified on Affigel 15 beads to which theterminal to the original start codon of GLT-1. The rationale of this
peptide P695 was coupled. The purified antibodies were testedªmass-taggingº was to achieve a lower mobility of the major mono-
against membrane vesicles from rat brain by using a 1:100 dilution.
meric glutamate transporter form, which enabled good resolution
The 73 kDa band was the only band detected, and the immunoreac-
of it from the nonspecific artifact bands (Figure 2A). Plasmid DNA
tivity of all bands observed after proteolysis was abolished by 50
of several of the transformants was isolated, and one of those that,
nmol of the peptide used to raise the antiserum. The preparation and
upon expression, gave rise to aspartate transport was selected. All characterization of the P694 antiserum, raised against the synthetic
of the expected features of the modified cysteineless GLT-1 were peptide SKSELDTIDSQHRMHED, has been described (Grunewald
verified by sequencing in both directions through the whole insert. and Kanner, 1995). The peptide corresponds to the sequence of
Upon expression, the activity of this construct (CL-H) was found to residues 496±512, located in the carboxyl tail of the transporter.
be 44% 6 2% of the wild-type GLT-1 (n 5 7). Single cysteine- Electrophoresis and immunoblotting were performed exactly as de-
containing transporters were made by using uracil containing single scribed (Grunewald and Kanner, 1995).
strand DNA derived from this construct.
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